Navigation Links
First Controlled Large-Scale Intervention Angiotensin Receptor,Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study,Demonstrates Significant Reduction in Blood Pressure and Protection,of Organs with Valsartan

Unprecedented Evidence for the Effectiveness of Hypertension Treatment Valsartan in Preventing Cardiovascular Events in Japanese Patients

TOKYO, April 26, 2007 /Xinhua-PRNewswire/ -- The clinical outcomes of the JIKEI HEART Study, the large-scale clinical trial headed by the Jikei University School of Medicine, was today published in the internationally renowned medical journal The Lancet. The study, involving more than 3,000 patients, is one of the largest cardiovascular intervention trials conducted in a Japanese population under realistic clinical settings. It also is the first large- scale study evaluating the benefits of the ARB, valsartan, in Japanese patients.

In the study, valsartan was added to conventional therapy to control blood pressure and protect against cardiovascular events and stroke. The results showed significant benefit with the use of valsartan, including a 39% decrease in cardiovascular events and a 40% decrease in stroke compared to conventional non-ARB therapy. Initiated in 2001, the JIKEI HEART Study was terminated earlier than anticipated at the request of the Data and Safety Monitoring Board due to superior outcomes for the valsartan group over the control group.

"Treatment of hypertension needs to account for blood pressure control but also should take into account the prevention of cardiovascular diseases over an extended period," said Seibu Mochizuki, M.D., PhD, formerly of Jikei University School of Medicine, chief investigator of the JIKEI HEART Study. "In the JIKEI HEART Study we accomplished both -- we achieved the lowest blood pressure value ever set in a morbidity/mortality outcomes trial and saw tremendous benefit for the valsartan arm in reducing the risk of cardiovascular events as well as stroke. Because of this, valsartan will play an important role in treating hypertension as it has been shown to lower blood pressure while being highly protective of end o
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model

Post Your Comments:
(Date:11/9/2009)..., Nov. 9 Milestone Scien...zed leader in computer-controlled injection techno... its patented, award-winning STA Single Tooth Ane...oup,s 15th year of TBSE titled "The Love Dentistry... Hilton. ,, The STA System is a computer-co...
(Date:11/9/2009)...ON, N.J., Nov. 9 Unwavering from i..., but recognizing today,s economic climate, Lutron...hetic laser systems, introduces the MOSAIC CO2, a ...r $50,000. ,, The MOSAIC CO2 offers many of th...ogy including scanning and stamping operation mode...
(Date:11/9/2009)..., Nov. 9 Thomson Reuters today a...CareFocus, a leading clinical surveillance solutio...nts in real-time and respond immediately to improv...ent. ,, This upgrade is available to current Ca...areFocus 2.0 contains several powerful enhancement...
Breaking Medicine Technology:Milestone Scientific to Exhibit at the 15th Anniversary of TBSE (The Best Seminar Ever) in Las Vegas 2Lutronic(R) Unleashes the New MOSAIC CO2 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Takes a Pro to Make Offices Pain Free 60246 1Takes a Pro to Make Offices Pain Free 60246 2InVitria Reports Successful Cell Culture Performance of Zap CHO a Defined and Cost Effective CHO Cell Culture Media Supplement 60242 1InVitria Reports Successful Cell Culture Performance of Zap CHO a Defined and Cost Effective CHO Cell Culture Media Supplement 60242 2NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 1NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 2NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 3
...Phase II Trial in Its Bavituximab Cancer P...STIN, Calif., Aug. 11 Peregrine,Pharmaceuticals, ... screening,and dosing has begun in a Phase II tria...bavituximab in combination with chemotherapy in pa...is the second Phase II study,evaluating bavituxima...
...privately-held,biopharmaceutical company, announce...t of three ongoing phase 2 clinical trials sponsor...logies Ltd, to investigate,CollaRx(R) BUPIVACAINE ...ive pain., Innocoll,s BUPIVACAINE SURGICAL IMPLAN...x of purified fibrillar collagen impregnated with ...
Other Medicine Technology:Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 4Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 2Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 3Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 4
(Date:11/9/2009)... Networking is everybody,s buzz...ns Money. StaffingClub.com enables Recruiters and ...cts to connect, share, communicate and close posit... to post their profiles and network with recruiter...2009 -- Current Job Market forces everyone to netw...
(Date:11/9/2009)...y to improve letter formation could boost self-est...(HealthDay News) -- Autistic children are more lik...e forming letters, than those without autism, rese...en, aged 8 to 13. Half of the study participants h...en scored within the normal range for perceptual r...
(Date:11/9/2009)...s implanted with new cells regained sexual functio...althDay News) -- Researchers were able to restore ... growing new penile tissue in the lab and implanti...plication is a ways off, researchers say the techn...e dysfunction in men. , "We were able to show t...
(Date:11/9/2009)...SHENZHEN, China, Nov. 9 /PRNewswire-FirstCall/ - H...om , announced today that Novartis, a US$41 billio...n 85% stake in HTDS, H1N1 Vaccine partner, Zhejian...5 million. Novartis of Switzerland will begin a fi...: the company will dramatically increase its inves...
(Date:11/9/2009)... Tomorrow may be too late when ...dition, according to TOPS Club, Inc. (Take Off Pou...rganization. , (Vocus) No... comes to preventing or improving a diabetes condi...s Sensibly), the nonprofit weight-loss support org...
Breaking Medicine News(10 mins):Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3
...LLAHASSEE, Fla., Feb. 18 Governor Charlie Crist h...co Free Florida Week to promote,smoke-free living ...ort that,are available to help them quit. During T...th FOX Sports Florida and Sun Sports, pro and coll...
...LLINGTON, Fla., Feb. 18 The Quantum Group,Inc. (N...& CEO Noel J. Guillama,commented on the Presid... Act,of 2009 into law yesterday. The new law allo...introduced. , The new law provides for approxi...
...KLAND, Calif., Feb. 18 In a dramatic move to unit...ect care RN organizations, the,United American Nur...,Organizing Committee, and the Massachusetts Nurse...d American Nurses-National,Nurses Organizing Commi...
... Express flights not always owne... standards of care , Clev... tragic airplane crash of Continental Flight 3407...on accident expert and lawyer Jamie R. Lebovitz po...
... JIVA™ Resveratrol Synergi...; More , Mount Kisco, NY ...s have generated as much excitement as resveratro...ional Institute on Aging created a stir when they ...
...st Schedules Conference Call for Wednesday, Februa... Feb. 17 Medifast, Inc. (NYSE: MED ), a leading...program announced today that it will hold an inves...d felon Barry Minkow and the Fraud Discovery Insti...
Other Medicine News:Health News:Governor Crist Proclaims Tobacco Free Florida Week Beginning February 27 2Health News:Governor Crist Proclaims Tobacco Free Florida Week Beginning February 27 3Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 2Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 3Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 4Health News:Aviation Expert Addresses Flight Safety Concerns 2Health News:Aviation Expert Addresses Flight Safety Concerns 3Health News:Aviation Expert Addresses Flight Safety Concerns 4Health News:Physician Develops Resveratrol Evidence-Based Nutraceutical for Heart Health 2Health News:Physician Develops Resveratrol Evidence-Based Nutraceutical for Heart Health 3Health News:Medifast, Inc. Responds to False Claims 2Health News:Medifast, Inc. Responds to False Claims 3Health News:Medifast, Inc. Responds to False Claims 4
... work, it is necessary to cool a specimen below ro...ted to most microtomes and will permit specimen co...conditions. The equipment consists of a cooling st...suited for operation with a base sledge microtome,...
...ew type of freezer designed to rapidly freeze spec... freezer tank which can hold object holders as wel... Clini-RF eliminates the need to use potentially h...uid nitrogen. In order to save power, the compress...
...ies Freezing Stages fit easily onto most microtome...rts and need only the AC supply and a trickle of r...diately and can be maintained indefinitely. Stage... temperatures can be set for different kinds of ti...
Glutamic Acid Decarboxylase (GAD65) Autoantibody ELISA
Medicine Products: